Medium vessel occlusions (MeVOs, ie, M2, M3, A2, A3, P2, and P3 segment occlusions) are
increasingly recognized as a target for endovascular treatment in acute ischemic stroke. It is …

Background Acute ischaemic stroke due to distal medium vessel occlusion (AIS-DMVO)
causes significant morbidity. Endovascular thrombectomy advancement has made treating …

Introduction: Expediting notification of lesions in acute ischemic stroke (AIS) is critical.
Limited availability of experts to assess such lesions and delays in large vessel occlusion …

Endovascular thrombectomy (EVT) has become standard of care for large vessel occlusion
strokes but current guidelines exclude a large proportion of patients from this highly effective …

Aims Endovascular therapy (EVT) for distal medium vessel occlusions (DMVOs) is a
potential frontier of acute ischemic stroke (AIS) treatment, but its efficacy against best …

Acute ischemic stroke is the leading cause of disability and among the leading causes of
mortality worldwide. Intravenous tissue plasminogen activator has been a cornerstone for …

Mechanical thrombectomy (MT) is frequently performed for distal medium vessel occlusions
(DMVO) of the anterior circulation in acute stroke patients. However, evidence for its clinical …

BACKGROUND AND PURPOSE: Endovascular therapy in acute ischemic stroke is rapidly
evolving. We explored physicians' treatment attitudes and practice in patients with acute …

Background and Purpose: Recent trials showed thrombectomy alone was comparable to
bridging therapy in patients with anterior circulation large vessel occlusion eligible for both …

Background M2 segment occlusions represent approximately one-third of non-lacunar
ischemic stroke and can lead to permanent neurological deficits. Various techniques are …